On this episode, I was joined by Dr. Kasem Akhras, Senior Director, Translational Access, Geneconomics & Outcomes Research – New Products at Novartis. Dr. Akhras and I discuss:
Key Topics
- His Book "Frontiers in Market Access"
- History of Market Access from the 1980's to now
- Where the Market Access function fits in within Product Development
- Market Access and Clinical Trials
- Over-Utilization
- Value Based Pricing
- US Pharmaceutical Prices
Dr. Akhras is a global Pharmaceutical Expert with 25 years of experience leading and building teams in the most critical functions in the Pharmaceutical Industry; Pricing, Reimbursement, Market Access, and Health Policy. Visionary, Passionate, and results driven leader. Well published in peer-reviewed journal and author of the book Frontiers in Market Access – A Practical Approach of Mastering Market Access. Dr. Akhras has held roles in Market Access and Health Economics at Novartis, Astrazeneca, Pfizer, Takeda, J&J and Sanofi. He is an Adjunct Professor at the University of Illinois at Chicago – Department of Pharmacy Systems, Outcomes and Policy.
